4563.TAnGes, Inc.
Nov 12, 2026 — Q3 2026 Earnings Announcement
Chart by TradingViewThe schedule
- Thu12Nov
AnGes is expected to report Q3 2026 financial results, providing crucial updates on capital runway and clinical pipeline progress against a backdrop of severe 52-week lows at $39.00.
- Thu25Feb
Release of audited full-year 2026 results and forward guidance, focusing acutely on FY2027 going-concern risks and commercialization timelines.
- Thu15Apr
- Thu10Jun
Expected primary equity offering or convertible debt issuance to address the critical imbalance between trailing cash ($281M) and mounting debt obligations ($723M).
